Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 85

Adding a pectoserratus block to improve pain management after shoulder surgery

Official title: Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement

Run by University of Minnesota · NCT06143306 · Data updated 2026-11-12

This study tests if adding a pectoserratus block to the usual pain relief method can help people feel less pain after shoulder surgery and use fewer opioids.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment110 (estimated)
SponsorUniversity of Minnesota
Academic / other
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedAugust 14, 2024
Main results expectedOctober 30, 2027
Study endsOctober 30, 2027
Registry record updatedNovember 2, 2026
Trial IDNCT06143306 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-85 undergoing total shoulder arthroplasty or reverse total shoulder arthroplasty.

Probably not a fit

Patients with pre-existing nerve damage, severe lung disease, or those currently using opioids may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of adding a pectoserratus block to the standard interscalene block for patients undergoing total shoulder arthroplasty. The goal is to assess whether this combination can enhance pain control and reduce the need for opioids post-surgery. Participants aged 18-85 will be randomly assigned to receive either the standard interscalene block or the combination of both blocks. The study aims to provide better pain management solutions for patients undergoing shoulder replacement procedures.

Why it matters

Potential benefit: If successful, this approach could lead to improved pain management and reduced opioid consumption for patients after shoulder surgery.

How similar studies have gone: Previous studies have shown that regional anesthesia techniques can improve pain management, suggesting potential success for this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing total shoulder arthroplasty or reverse total shoulder arthroplasty;
* Patients aged 18-85 years old.

Exclusion Criteria:

* Patients who have an exclusion to regional anesthesia such as pre-existing nerve damage to their brachial plexus or infection at the site of injection.
* Patients who have exclusion to interscalene blockade such as severe lung disease.
* Non-English speakers will be excluded because pain scales are not validated in other languages and there is lack of standardization of pain reporting.
* Pregnant patients
* Patients who are currently using opioids and patients with a diagnosis of chronic pain will be excluded.

Where it's running

  • University of Minnesota
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: Jacob Hutchins, MD, MHA — University of Minnesota
  • Study coordinator: Candace Nelson
  • Email: nelso377@umn.edu
  • Phone: 612-625-7116

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.